Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Discover why Viking Therapeutics, Inc. surged 50% as GLP-1 market buzz and strong VK2735 results renew investor optimism.

Viking Therapeutics (VKTX) shares have seen some interesting moves over the past month, climbing more than 16%. Investors are watching closely, with a particular focus on how the biotech’s pipeline ...

With significant upside potential and hedge fund interest, Viking Therapeutics, Inc. (NASDAQ: VKTX) secured a spot on our list of the 15 stocks set to explode in 2026.

-- Piper Sandler 37th Annual Healthcare ConferenceDetails: Viking management will participate in a fireside chat and in investor meetingsConference Dates: December 2-4, 2025Fireside Chat Date/Timing: ...

Viking Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing novel therapies for metabolic and endocrine disorders. Here's what investors should know.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Riot Platforms Inc (Symbol: RIOT), where a total of 263,138 contracts have traded so far, ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...